Vita 34 AG Namens-Aktien o.N.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

44.47%

Market Cap

47.24 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.36 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE2.71 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:55:46 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW2.922.71
PREV. DAY'S PRICE2.86 (07/20)
CHANGE DAY BEFORE
-0.15
-5.24 %
52 WEEK HIGH / LOW7.5 (08/27)2.71 (07/21)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.12-0.70-0.360.010.06
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
---291.0048.50
PRICE - BOOK RATIO
3.885.0814.70--
PRICE - SALES RATIO
1.080.871.19--
PRICE - CASH FLOW RATIO
9.008.1326.97--
Further Key Figures

Master Data

WKN
A0BL84
ISIN
DE000A0BL849
SYMBOL
V3V
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Vita 34
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
17.43 Mil.
MARKET CAPITALISATION
47.24 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-12.86 %
-27.35 %
-39.24 %
-52.87 %
-44.47 %
-44.12 %
-83.72 %
-54.07 %
HIGH3.113.804.485.757.507.5017.406.00
LOW2.712.712.712.712.712.712.712.71

Dividende

pro Aktie
Vita 34 does not deliver dividend information

Company profile

FamiCord AG engages in the collection, logistics, processing, and storage of stem cells from umbilical cord blood, umbilical cord tissue, and other postnatal tissues, serving as a full-service provider for cryopreservation. It also engages in the development of products and drugs derived from cells, tissues, and blood for medical applications. Additionally, FamiCord is active in Cell & Gene therapies and operates as a CDMO. The company was founded by Eberhard F. Lampeter on April 28, 1997 and is headquartered in Leipzig, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

(in 38 days)
08/28/26Q2 2026 Earnings Release
(in 125 days)
11/23/26Q3 2026 Earnings Release
(in 288 days)
05/05/27Q4 2026 Earnings Release
(in 316 days)
06/02/27Q1 2027 Earnings Release
(in 406 days)
08/31/27Q2 2027 Earnings Release